10.6084/m9.figshare.5992117.v1 Peter Nash Peter Nash Philip Mease Philip Mease Iain McInnes Iain McInnes Proton Rahman Proton Rahman Christopher Ritchlin Christopher Ritchlin Ricardo Blanco Ricardo Blanco Eva Dokoupilova Eva Dokoupilova Mats Andersson Mats Andersson Radhika Kajekar Radhika Kajekar Shephard Mpofu Shephard Mpofu Luminita Pricop Luminita Pricop Additional file 1: of Efficacy and safety of secukinumab administration by autoinjector in patients with psoriatic arthritis: results from a randomized, placebo-controlled trial (FUTURE 3) Springer Nature 2018 Psoriatic arthritis Secukinumab Autoinjector Interleukin-17a FUTURE 3 study 2018-03-15 05:00:00 Journal contribution https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_of_Efficacy_and_safety_of_secukinumab_administration_by_autoinjector_in_patients_with_psoriatic_arthritis_results_from_a_randomized_placebo-controlled_trial_FUTURE_3_/5992117 Figure S1. Showing study design, Table S1. Presenting independent ethics committees (IECs) or institutional review boards (IRB) by study center, Table S2. Presenting a summary of observed efficacy data at week 52 among patients randomized to secukinumab at baseline, Table S3. Presenting patient-reported acceptability of the autoinjector, and Table S4. Presenting SAEs by SOC reported across the entire study period. (DOCX 438 kb)